ClinicalTrials.gg
CompletedNCT05047809Updated Mar 13, 2024

The Effect of "Jinchuang Ointment" (JCO) on the Treatment of Wounds in Patients With Hansen's Disease.

An interventional study of "Jingchuang Ointment"(JCO) and Regular Treatment in Leprosy, Hansen's Disease and Wounds, sponsored by Lo-Sheng Sanatorium. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-03-13.

Sponsored by Lo-Sheng Sanatorium · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
20 Years to 85 Years
Sex
All
01

Study summary

This study aimed to evaluate the effect of a Chinese herb complex "Jinchuang ointment" (JCO) on the treatment of chronic nonhealing wounds in patients with Hansen's disease and its mechanism.

Read the detailed description

20 patients who were hospitalized at Lo-Sheng Sanatorium, Ministry of Health and Welfare, were recruited. Ulcers were treated in this study using the four-step wound care guidelines, observation, rinsing, cleaning, and dressing, published by the Taiwan Food and Drug Administration. Besides, JCO was applied once a day on the wounds.

Basic data of each case were collected, and a monthly wound record was used to follow the condition of the wound healing of these patients.

02

Conditions studied

  • Leprosy
  • Hansen's Disease
  • Wounds

Keywords

  • Leprosy
  • Hansen's disease (HD)
  • Jinchuang Ointment (JCO)
  • wounds
  • anti-inflammation
03

In context

Leprosy

52 studies on the registry are indexed under Leprosy; 13 are open to participants now.

This study's enrollment of 20 is below the median of 70 across 41 interventional studies indexed under Leprosy.

Browse Leprosy studies →

Lead sponsor

Lo-Sheng Sanatorium is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hanson's patients
  • Meet the definition of chronic wound

Exclusion criteria

Exclusion Criteria:

  • Kidney disease
  • Parathyroid disease
  • Malignant tumors.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    "Jingchuang Ointment"(JCO) group

    Ulcers were treated in this study using the four-step wound care guidelines, observation, rinsing, cleaning, and dressing, published by the Taiwan Food and Drug Administration. Besides, JCO was applied once a day on the wounds, last 3 months. "Jingchuang Ointment" (JCO) is made by Chuang Song Zong Pharmaceutical Co., Ltd. (Taiwan)

    Other: "Jingchuang Ointment"(JCO)

  • Other
    Regular treatment group

    Ulcers were treated in this study using the four-step wound care guidelines, observation, rinsing, cleaning, and dressing, published by the Taiwan Food and Drug Administration.

    Other: Regular Treatment

Interventions

  • Other"Jingchuang Ointment"(JCO)

    Applied once a day on the wounds

    Also known as: Chuang Song Zong Pharmaceutical Co., Ltd. (Taiwan)

  • OtherRegular Treatment

    Do not use the "Jingchuang Ointment"(JCO), as the regular treatment as usual.

06

What researchers measure

Primary outcomes

  1. The size of wound area

    Length times width

    Time frame: Changes in wound size in 3 months

07

Study locations

1 site
  • Lo-Sheng Sanatorium
    Taoyuan City, 33351, Taiwan
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05047809
Lead sponsor
Lo-Sheng Sanatorium
Responsible party
Hsu Wei Hung (Director of chinese medicine, Lo-Sheng Sanatorium) — Principal investigator
First posted
Sep 17, 2021
Start date
Aug 7, 2021
Primary completion
Sep 5, 2021
Completion
May 5, 2022
Last update
Mar 13, 2024

Study contacts

Wei-Hung Hsu
principal investigator · Lo-Sheng Sanatorium

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion